Prolonged higher dose methylprednisolone versus conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)

BACKGROUND: Dysregulated systemic inflammation is the primary driver of mortality in severe coronavirus disease 2019 (COVID-19) pneumonia. Current guidelines favour a 7–10-day course of any glucocorticoid equivalent to dexamethasone 6 mg daily. A comparative randomised controlled trial (RCT) with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Salton, Francesco, Confalonieri, Paola, Centanni, Stefano, Mondoni, Michele, Petrosillo, Nicola, Bonfanti, Paolo, Lapadula, Giuseppe, Lacedonia, Donato, Voza, Antonio, Carpenè, Nicoletta, Montico, Marcella, Reccardini, Nicolò, Meduri, Gianfranco Umberto, Ruaro, Barbara, Confalonieri, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650195/
https://www.ncbi.nlm.nih.gov/pubmed/36356972
http://dx.doi.org/10.1183/13993003.01514-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650195/
https://www.ncbi.nlm.nih.gov/pubmed/36356972
http://dx.doi.org/10.1183/13993003.01514-2022

Ejemplares similares